Connect with us

National

Sanofi to start human trials of its second Covid vaccine candidate | – Macau Business

International, MNA | French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the…

Published

on

French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second Covid-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Sanofi and US company Translate Bio are developing the vaccine based on messenger RNA technology.
The phase 1 and 2 trials aim to verify that the vaccine is not dangerous and to provide initial information on its effectiveness.
Phase 3 would be carried out on many more patients to determine its effectiveness. 

Click here to view the original article.